Relypsa's P2P Acquisition

Relypsa raised a round of funding on July 21, 2016. Investors include Galenica Sante.

Relypsa is a clinical-stage biopharmaceutical company leading the discovery and development of non-absorbed polymeric drugs for applications in cardiovascular and renal disease. Relypsa's lead product…

Articles about Relypsa's P2P Acquisition: